扩大聚合酶链反应面板尿路病原体鉴定和治疗建议在尿路感染。

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY
Therapeutic Advances in Urology Pub Date : 2025-06-10 eCollection Date: 2025-01-01 DOI:10.1177/17562872251342421
Lindsey Leech, Christopher Bigley, Marshall Chew, Ashley Crawford, JeanAnn Vawter, Manish P Patel
{"title":"扩大聚合酶链反应面板尿路病原体鉴定和治疗建议在尿路感染。","authors":"Lindsey Leech, Christopher Bigley, Marshall Chew, Ashley Crawford, JeanAnn Vawter, Manish P Patel","doi":"10.1177/17562872251342421","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Urinary tract infections (UTI) are common and costly, but standard urine culture (SUC) diagnostic tests have significant limitations. Emerging molecular techniques like multiplex polymerase chain reaction (PCR) offer rapid simultaneous detection of uropathogens and antimicrobial resistance (AMR) genes allowing timely targeted therapy.</p><p><strong>Objectives: </strong>To compare the performance of Urine-ID™ test, an expanded multiplex PCR panel designed to detect 26 uropathogens and 49 AMR markers against SUC for pathogen detection in individuals with suspected complicated UTI.</p><p><strong>Design and methods: </strong>A total of 56 urine specimens from individuals aged 50 and older, who exhibited UTI symptoms and failed previous therapy based on SUC results, were retrospectively analyzed using Urine-ID<sup>™</sup> using the TaqMan<sup>®</sup> OpenArray plates on the QuantStudio 12K Flex Real-Time PCR System. Results of simultaneously collected PCR and SUC were compared at patient follow-ups.</p><p><strong>Results: </strong>Of the 56 suspected UTI cases, SUC failed to detect pathogens in 19.64% (<i>N</i> = 11/56) of the specimens while PCR yielded negative results in 7.14% (<i>N</i> = 4/56) of cases. SUC identified a specific organism in 50% (<i>N</i> = 28/56) while PCR detected at least one uropathogen in 92.86% (<i>N</i> = 52/56) of specimens. Data also revealed that a nonspecific result, \"Mixed urogenital flora\" (MUG), was the most frequent outcome (<i>N</i> = 18/45) obtained with SUC among positive samples. While SUC identified a single pathogen in 92.80% (<i>N</i> = 26/28) of positive specimens, PCR detected additional co-infecting uropathogens in 71.20% (<i>N</i> = 37/52) of positive samples. Of the 18 MUG and 11 negative samples using SUC, PCR identified treatable pathogens in 13 and 7 samples, respectively.</p><p><strong>Conclusion: </strong>These results highlight the effectiveness of expanded real-time PCR panels for quickly and accurately identifying uropathogens, surpassing traditional SUC sensitivity. Adopting these advanced molecular techniques, particularly in suspected complicated UTI cases, improves diagnosis efficiency, leading to faster pathogen identification and treatment, ultimately reducing patient morbidity.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"17 ","pages":"17562872251342421"},"PeriodicalIF":2.6000,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152380/pdf/","citationCount":"0","resultStr":"{\"title\":\"Expanded PCR panel for uropathogen identification and treatment recommendations in urinary tract infections.\",\"authors\":\"Lindsey Leech, Christopher Bigley, Marshall Chew, Ashley Crawford, JeanAnn Vawter, Manish P Patel\",\"doi\":\"10.1177/17562872251342421\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Urinary tract infections (UTI) are common and costly, but standard urine culture (SUC) diagnostic tests have significant limitations. Emerging molecular techniques like multiplex polymerase chain reaction (PCR) offer rapid simultaneous detection of uropathogens and antimicrobial resistance (AMR) genes allowing timely targeted therapy.</p><p><strong>Objectives: </strong>To compare the performance of Urine-ID™ test, an expanded multiplex PCR panel designed to detect 26 uropathogens and 49 AMR markers against SUC for pathogen detection in individuals with suspected complicated UTI.</p><p><strong>Design and methods: </strong>A total of 56 urine specimens from individuals aged 50 and older, who exhibited UTI symptoms and failed previous therapy based on SUC results, were retrospectively analyzed using Urine-ID<sup>™</sup> using the TaqMan<sup>®</sup> OpenArray plates on the QuantStudio 12K Flex Real-Time PCR System. Results of simultaneously collected PCR and SUC were compared at patient follow-ups.</p><p><strong>Results: </strong>Of the 56 suspected UTI cases, SUC failed to detect pathogens in 19.64% (<i>N</i> = 11/56) of the specimens while PCR yielded negative results in 7.14% (<i>N</i> = 4/56) of cases. SUC identified a specific organism in 50% (<i>N</i> = 28/56) while PCR detected at least one uropathogen in 92.86% (<i>N</i> = 52/56) of specimens. Data also revealed that a nonspecific result, \\\"Mixed urogenital flora\\\" (MUG), was the most frequent outcome (<i>N</i> = 18/45) obtained with SUC among positive samples. While SUC identified a single pathogen in 92.80% (<i>N</i> = 26/28) of positive specimens, PCR detected additional co-infecting uropathogens in 71.20% (<i>N</i> = 37/52) of positive samples. Of the 18 MUG and 11 negative samples using SUC, PCR identified treatable pathogens in 13 and 7 samples, respectively.</p><p><strong>Conclusion: </strong>These results highlight the effectiveness of expanded real-time PCR panels for quickly and accurately identifying uropathogens, surpassing traditional SUC sensitivity. Adopting these advanced molecular techniques, particularly in suspected complicated UTI cases, improves diagnosis efficiency, leading to faster pathogen identification and treatment, ultimately reducing patient morbidity.</p>\",\"PeriodicalId\":23010,\"journal\":{\"name\":\"Therapeutic Advances in Urology\",\"volume\":\"17 \",\"pages\":\"17562872251342421\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152380/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562872251342421\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872251342421","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:尿路感染(UTI)是一种常见且昂贵的疾病,但标准尿培养(SUC)诊断测试有明显的局限性。多重聚合酶链反应(PCR)等新兴分子技术可以快速同时检测尿路病原体和抗微生物药物耐药性(AMR)基因,从而实现及时的靶向治疗。目的:比较Urine-ID™测试的性能,该测试是一种扩展的多重PCR检测面板,用于检测26种尿路病原体和49种针对SUC的AMR标记,用于疑似复杂UTI患者的病原体检测。设计和方法:对56例50岁及以上患者的尿液标本进行回顾性分析,这些患者均表现出尿路感染症状,且既往的SUC结果治疗失败,使用尿液- id™,采用QuantStudio 12K Flex实时PCR系统上的TaqMan®OpenArray板。同时采集的PCR和SUC结果在患者随访时进行比较。结果:56例疑似UTI病例中,SUC未检出病原菌的占19.64% (N = 11/56), PCR阴性的占7.14% (N = 4/56)。50% (N = 28/56)的标本经SUC检出一种特异性病原菌,92.86% (N = 52/56)的标本经PCR检出至少一种尿路病原体。数据还显示,在阳性样本中,使用SUC获得的非特异性结果“混合泌尿生殖菌群”(MUG)是最常见的结果(N = 18/45)。在阳性标本中,SUC检出单一病原菌的占92.80% (N = 26/28), PCR检出合并感染尿路病原菌的占71.20% (N = 37/52)。在使用SUC检测的18份MUG和11份阴性样本中,PCR分别鉴定出13份和7份可治疗的病原体。结论:这些结果突出了扩展的实时PCR检测板在快速、准确地鉴定尿路病原体方面的有效性,超过了传统的SUC灵敏度。采用这些先进的分子技术,特别是在疑似复杂的尿路感染病例中,可以提高诊断效率,更快地识别和治疗病原体,最终降低患者的发病率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Expanded PCR panel for uropathogen identification and treatment recommendations in urinary tract infections.

Background: Urinary tract infections (UTI) are common and costly, but standard urine culture (SUC) diagnostic tests have significant limitations. Emerging molecular techniques like multiplex polymerase chain reaction (PCR) offer rapid simultaneous detection of uropathogens and antimicrobial resistance (AMR) genes allowing timely targeted therapy.

Objectives: To compare the performance of Urine-ID™ test, an expanded multiplex PCR panel designed to detect 26 uropathogens and 49 AMR markers against SUC for pathogen detection in individuals with suspected complicated UTI.

Design and methods: A total of 56 urine specimens from individuals aged 50 and older, who exhibited UTI symptoms and failed previous therapy based on SUC results, were retrospectively analyzed using Urine-ID using the TaqMan® OpenArray plates on the QuantStudio 12K Flex Real-Time PCR System. Results of simultaneously collected PCR and SUC were compared at patient follow-ups.

Results: Of the 56 suspected UTI cases, SUC failed to detect pathogens in 19.64% (N = 11/56) of the specimens while PCR yielded negative results in 7.14% (N = 4/56) of cases. SUC identified a specific organism in 50% (N = 28/56) while PCR detected at least one uropathogen in 92.86% (N = 52/56) of specimens. Data also revealed that a nonspecific result, "Mixed urogenital flora" (MUG), was the most frequent outcome (N = 18/45) obtained with SUC among positive samples. While SUC identified a single pathogen in 92.80% (N = 26/28) of positive specimens, PCR detected additional co-infecting uropathogens in 71.20% (N = 37/52) of positive samples. Of the 18 MUG and 11 negative samples using SUC, PCR identified treatable pathogens in 13 and 7 samples, respectively.

Conclusion: These results highlight the effectiveness of expanded real-time PCR panels for quickly and accurately identifying uropathogens, surpassing traditional SUC sensitivity. Adopting these advanced molecular techniques, particularly in suspected complicated UTI cases, improves diagnosis efficiency, leading to faster pathogen identification and treatment, ultimately reducing patient morbidity.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信